[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Infants

What is the purpose of the study? (in Layman's terms, please describe the study)

The purpose of this study is to:
• Test how safe the vaccine is and how well your child can tolerate the research study vaccine, V114, compared to Prevnar 13.
• Test how much the body can respond the study vaccine, V114.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:


Study Phase:

Phase III

Patient Age Group:


Principal Investigator:

Leonard B Weiner

Who can I contact for more information?

Name: Kristen Fluno
Phone: 315-464-6331
Email: flunok@upstate.edu

Return to Previous Page || Search Again